SBI/SeraMir Control spike-in Small RNA and qPCR assay/RA805A-1/100 Assays
基因編輯
商品編號
RA805A-1
品牌
SBI
公司
System Biosciences(SBI)
公司分類(lèi)
biomarker profiling
商品信息
.img-style{heigth:450px;width:450px;}
Overview:
Get extra assurance for your SeraMir qPCR profiling studies
To help researchers with their SeraMir qPCR profiling studies,
SBI
offers the SeraMir Spike-in RNA Control and qPCR Assay. This product gives researchers the
ABI
lity to control for exoRNA recovery, tailing, and
CDN
A synthesis by spiking in known quantities of a control RNA during exoRNA isolation—can be used directly on the 384-well SeraMir profiling plates or in an individual control spike-in qPCR assay.
Choose the SeraMir Kit that’s right for you
Cat. #
Name
Kit includes
ExoQuick or ExoQuick-TC
SeraMir RNA columns and reagents
SeraMir
CDN
A synthesis and amplification reagents
384-well plate miRNAs for human, mouse, or rat
RA800A-1
Complete SeraMir Exosome RNA Amplification Kit
?
RA800TC-1
Complete SeraMir Exosome RNA Amplification Kit for Media and Urine
?
RA806A-1
SeraMir Exosome RNA Purification Kit
?
?
RA806TC-1
SeraMir Exosome RNA Purification Kit for Media and Urine
?
?
RA808A-1
SeraMir Exosome RNA Purification Column Kit
?
?
?
RA820A-1
Human Complete SeraMir Exosome RNA Amplification and Profiling Kit
RA820TC-1
Human Complete SeraMir Exosome RNA Amplification and Profiling Kit for Media and Urine
RA821A-1
Mouse Complete SeraMir Exosome RNA Amplification and Profiling Kit
RA821TC-1
Mouse Complete SeraMir Exosome RNA Amplification and Profiling Kit for Media and Urine
RA822A-1
Rat Complete SeraMir Exosome RNA Amplification and Profiling Kit
RA822TC-1
Rat Complete SeraMir Exosome RNA Amplification and Profiling Kit for Media and Urine
How It Works:
Use the SeraMir spike-in RNA control in a qPCR assay to control for exoRNA recovery, tailing, and
CDN
A synthesis.
If 5 ?L of SeraMir Spike-in RNA was used during exoRNA isolation, then you should expect to observe a C
t
of about 15 to 20.
Citations:
Nakano, T, et al. (2017) Hepatic miR-301a as a Liver Transplant Rejection Bio
Marker
? And Its Role for Interleukin-6 Production in Hepatocytes.
OMICS
. 2017 Jan 1; 21(1):55-66. PM ID: 28271982
Holliday, LS, et al. (2017) Exosomes: novel regulators of bone remodelling and potential therapeutic agents for orthodontics.
Orthod Craniofac Res
. 2017 Jun 1;:95-99. PM ID: 28643924
Faust, A, et al. (2017) Urinary bladder extracellular matrix hydrogels and matrix-bound vesicles differentially regulate central nervous system neuron vi
ABI
lity and axon growth and branching.
J
Biomat
er Appl
. 2017 Apr 1; 31(9):1277-1295. PM ID: 28447547
Koyama, S, et al. (2017) Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation.
ESC Heart Fail
. 2017 May 1; 4(2):112-121. PM ID: 28451447
Zhang, R, et al. (2017) Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Biochem. Biophys. Res. Commun.
. 2017 Jun 13;. PM ID: 28623135
Huleihel, L, et al. (2017) Matrix bound nanovesicles recapitulate extracellular matrix effects on macrophage phenotype.
Tissue Eng Part A
. 2017 Jun 4;. PM ID: 28580875
Peng, Y, Huleihel, L & Cardenes, N. (2017) Different MiroRNA Expression In MSC-Derived Exosomes: IPF Patients And Age-Matched Normal Individuals.
Conference
. ;. Link: Conference
Protocol, IIEI. (2017) List of Components.
Product
. ;. Link: Product
Tsukita, S, et al. (2017) MicroRNAs 106b and 222 Improve Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes via Pancreatic β-Cell Proliferation.
EBioMedicine
. 2017 Feb 1; 15:163-172. PM ID: 27974246
Josson, S, Gururajan, M & WKChung, L. (2017) miRNA Characterization from the Extracellular Vesicles.
bio-protocol
. ; 7(4). Link: bio-protocol
Val, S, et al. (2017) Purification and characterization of microRNAs within middle ear fluid exosomes: implication in otitis media pathophysiology.
Pediatr. Res.
. 2017 Apr 5;. PM ID: 28157838
Sueta, A, et al. (2017) Abstract P1-02-13: Differential expression of exosomal miRNAs between breast cancer patients with recurrence and no-recurrence.
Abstract
. ;. Link: Abstract
Selmaj, I, et al. (2017) Global Exosome Transcriptome Profiling Reveals Bio
Marker
s for Multiple Sclerosis.
Ann. Neurol.
. 2017 Apr 15;. PM ID: 28411393
Zhou, X, et al. (2017) Characterization of mouse serum exosomal small RNA content: The origins and their roles in modulating inflammatory response.
Oncotarget
. 2017 Jun 27; 8(26):42712-42727. PM ID: 28514744
Hubal, MJ, et al. (2017) Circulating
ADI
pocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass.
Obesity (Silver Spring)
. 2017 Jan 1; 25(1):102-110. PM ID: 27883272
Yan, IK, et al. (2016) Circulating Extracellular RNA
Marker
s of Liver Regeneration.
PLoS ONE
. 2016 Jul 15; 11(7):e0155888. PM ID: 27415797
Huleihel, L, et al. (2016) Matrix-bound nanovesicles within ECM bioscaffolds.
Sci Adv
. 2016 Jun 1; 2(6):e1600502. PM ID: 27386584
Kudo, M. (2016) Speaker’s Lecture Abstracts.
Liver Cancer
. ; 5(1):1–94. Link: Liver Cancer
Clayton, A, et al. (2016) The 2nd United Kingdom Extracellular Vesicle Forum Meeting Abstracts: 15 December 2015, Hadyn Ellis Building, Cardiff University..
J Extracell Vesicles
. 2016 Mar 1; 5:30924. PM ID: 26928673
Reza, AM, et al. (2016) Human
ADI
pose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells.
Sci Rep
. 2016 Dec 8; 6:38498. PM ID: 27929108
產(chǎn)品貨號:1703.2